Lawrence N. Shulman, MD, on Survival as a Measure of Quality and Advances in Therapy
2016 Quality Care SymposiumLawrence N. Shulman, MD, of the University of Pennsylvania, discusses his paper, which explores lessons learned from analyses of the National Cancer Data Base. (Abstract 173)
Related Videos
Lee N. Newcomer, MD, on Assessing Quality: Payer Perspective
Lee N. Newcomer, MD, of the UnitedHealth Group, gives his perspective on how to assess quality in the age of precision medicine.
Kerin B. Adelson, MD, on Improving Cancer Staging
Kerin B. Adelson, MD, of the Yale Cancer Center, discusses an electronic decision support tool to capture staging data. This information allows automated reports for clinical trial...
Sandra L. Wong, MD's, Oral Abstract Discussion: Expert Perspective
Sandra L. Wong, MD, of the Dartmouth-Hitchcock Medical Center, summarizes three abstracts for which she was the discussant. The topics were rates of surgical site infections, an on...
Robert Miller, MD: CancerLinQ Update
Robert Miller, MD, ASCO’S Vice President of Quality and Guidelines, discusses CancerLinQ, the “big data” technology platform, and implementation of a rapid learning system for onco...
Craig Earle, MD, on The Science of Quality
Craig Earle, MD, of Canada’s Institute for Clinical Evaluative Sciences, summarizes abstracts discussed in a ticketed session that he co-chaired on this key topic. (Abstracts 173, ...
